New Pharmatech CEO expects larger external sales – but this won't weaken relationship with Novo Nordisk

Ulla Grove Krogsgaard Thomsen is the new CEO for Novo Nordisk Pharmatech, and according to the CEO, external sales will take up more space in the future. At the same time, she establishes that this will not weaken the firm's relationship with parent company Novo Nordisk.

New CEO for Novo Nordisk Pharmatech Ulla Grove Krogsgaard Thomsen. | Photo: Novo Nordisk Pharmatech / PR

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list, which handles online sales.

Further reading

Related articles

Latest news

See all jobs